{"id":162515,"date":"2022-06-09T01:55:19","date_gmt":"2022-06-09T05:55:19","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/first-patient-dosed-in-second-phase-2-add-on-ketamine-trial-in-treatment-resistant-depression-trd\/"},"modified":"2024-08-18T11:45:09","modified_gmt":"2024-08-18T15:45:09","slug":"first-patient-dosed-in-second-phase-2-add-on-ketamine-trial-in-treatment-resistant-depression-trd","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/first-patient-dosed-in-second-phase-2-add-on-ketamine-trial-in-treatment-resistant-depression-trd.php","title":{"rendered":"First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)"},"content":{"rendered":"<p><![CDATA[Dosing has commenced in HMNC Brain Health and Develco Pharma\u2019s Phase 2 oral prolonged-release Ketamine (KET01) Study]]><\/p>\n<p>Go here to read the rest:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2022\/06\/08\/2458726\/0\/en\/First-patient-dosed-in-second-Phase-2-add-on-Ketamine-Trial-in-Treatment-Resistant-Depression-TRD.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)\">First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Go here to read the rest: First patient dosed in second Phase 2 add-on Ketamine Trial in Treatment-Resistant Depression (TRD) <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/first-patient-dosed-in-second-phase-2-add-on-ketamine-trial-in-treatment-resistant-depression-trd.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-162515","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162515"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=162515"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/162515\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=162515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=162515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=162515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}